Sample Pages/Table of Contents
Publication Details
BioWorld Biotechnology State of the Industry Report 2009
Product Code: S09406
Published: March 2009
Pages: 425
Format: Print and PDF
Price: $599* (plus $17.95 s&h)
Publisher
BioWorld Today
Guarantee
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
|
 |
The BioWorld Biotechnology
State of the Industry Report 2009
The ultimate industry report measuring the progress of business, science and regulation in biotechnology.
"This comprehensive status report on the biotechnology industry, published by
BioWorld Today, is a required reference for analysts and investors in biotech, and is a must-have resource for biotech executives in need of factual data that will help show them which way the sector is heading."
With the BioWorld Biotechnology State of the Industry Report 2009, you can tap into 425 pages of proprietary market research that reveals critical data and financial information about trends affecting the biotechnology industry in the U.S. It contains more than 300 up-to-date tables and charts, plus special analysis sections on Wall Street, the FDA, R&D and biotech in Europe.
The new BioWorld Biotechnology State of the Industry Report 2009 gives you every piece of information available to help you analyze developments in the biotechnology industry and stay ahead of the curve. An example of some of the data you receive includes:
- Money raised by biotechnology companies last year
- Follow-on public offerings
- After-market performance (IPOs)
- After-market performance for follow-on offerings
- IPOs for the past 4 years
- Follow-on offerings for the past 4 years
- Gross proceeds of biotech public stock offerings for the past 10 years
- Venture capital and other financings of private biotechnology firms
- Milestones and equity investments from corporate partners
- Grants and awards to biotech companies
- New agreements between biotech and big-pharma
- Modified and terminated agreements between biotech and big-pharma
- Ag-bio collaborations
- Manufacturing, marketing and distribution agreements
- Biotech and university/nonprofit institution collaborations
- Mergers and acquisitions: completed, pending and terminated
- And much more!
By combining these tables and charts with expert opinions from industry thought-leaders, the
BioWorld Biotechnology State of the Industry Report 2009 is the prerequisite for creating dynamic data-driven presentations, preparing business plans and marketing strategies, and deepening your understanding of the biotechnology industry.
People who need this report:
- Biotechnology and pharmaceutical executives
- Start-ups
- Heads of R&D
- Analysts
- Investors
- Law firms serving the sector
- Economic development organizations
- Technology transfer officers
How To Order:
Order our BioWorld Biotechnology State of the Industry Report 2009 by choosing an option below. Or call us at 1-800-688-2421 or 1-404-262-5476 and mention priority code
S09406-EM/7601.
|
